Virtual screening and network pharmacology-based synergistic coagulation mechanism identification of multiple components contained in compound Kushen Injection against hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is a primary liver malignancy commonly encountered in the setting of chronic liver disease and cirrhosis. Compound Kushen Injection (CKI) has been widely used in HCC, however, the underlying mechanisms are scarce. Objective: To explore the molecular mechani...
Saved in:
| Main Authors: | Kejun Zhou, Mengyi Xie, Yu Liu, Lei Zheng, Juan Pu, Cheng Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Journal of Ayurveda and Integrative Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0975947624001700 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive evaluation of compound Kushen injection combined with zoledronic acid in treating bone metastasis cancer pain based on meta-analysis and decision tree model
by: Xi Zhao, et al.
Published: (2025-01-01) -
Combination of Compound Kushen injection with first-line treatment versus first-line treatment alone for advanced colorectal cancer: a study protocol for a multicenter, openlabel, randomized controlled trial
by: Jingyuan Wu, et al.
Published: (2024-12-01) -
Role of Coagulation Factors in Hepatocellular Carcinoma: A Literature Review
by: Azeem Azam, et al.
Published: (2024-12-01) -
Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway
by: Luo X, et al.
Published: (2025-01-01) -
Research Progress on Tofu Coagulants and Their Coagulation Mechanisms
by: Yuhan Geng, et al.
Published: (2024-10-01)